Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer
for Bladder (Urothelial, Transitional Cell) Cancer
5 locations incl. Queen Creek
Sponsor: Protara Therapeutics
Sex: All·Age: 18+
Code: NCT07480356·Phase 3·Recruiting·Listed Mar 2026